Primerica Q3 2026 Earnings: Investment Sales Rise 19% as Term Life Profit Falls

Primerica (NYSE: PRI) reported Q3 2026 revenue of $901.7 million, up 7% from $839.9 million, while diluted EPS increased 6% to $6.76 from $6.35. Investment and Savings Products drove the top-line increase, but a 12% decline in Term Life adjusted operating income and a smaller actuarial remeasurement gain limited growth in pre-tax and net income. Share repurchases and a lower diluted share count helped EPS grow faster than net income.

Core Financial Results

GAAP net income rose only 1% even as revenue increased 7%. The quarter included an $11.8 million pre-tax gain from remeasuring future policy benefits, compared with a $23.1 million gain in the prior-year quarter, reducing the favorable year-over-year contribution by approximately $11.3 million.

Adjusted results followed a similar pattern: adjusted operating revenue rose 8%, but adjusted operating income before taxes increased by less than 1%.

Business and Segment Performance

Investment and Savings Products was the clear growth engine, while Term Life revenue was nearly unchanged and segment profit declined. Corporate and Other Distributed Products posted higher revenue and income from a smaller base.

Investment and Savings Products sales reached $4.4 billion, up 19%, supported by client demand and expanded product offerings. Client asset values increased 10% to $139.6 billion, with favorable equity markets also contributing to the increase, while quarterly net inflows totaled $407 million.

Term Life showed weaker distribution metrics. The life-licensed sales force declined 3% to 147,058, recruits fell 10%, and newly licensed representatives decreased 14%. Policies issued fell 7% to 73,813, while issued face amount declined 5% to $25.7 billion. Life productivity remained at 0.17.

Adjusted direct premiums increased 3%, but net premiums were nearly unchanged at $450.5 million. Despite that premium stability, Term Life adjusted operating income fell 12%; the release did not identify a single cause for the decline, though the quarter included the annual actuarial assumption update.

Profitability, Capital Returns, and Balance Sheet

Total benefits and expenses increased approximately 11% to $629.7 million, outpacing revenue growth and leaving pre-tax income nearly flat. Sales commissions rose to $210.9 million from $174.7 million as the investment business expanded, while other operating expenses increased to $94.4 million from $87.3 million.

Primerica returned $159 million to shareholders during the quarter, comprising $122 million of share repurchases and $37 million of dividends. Average diluted shares declined approximately 5% to 30.8 million, helping diluted EPS rise faster than net income. The board also approved a $1.20-per-share dividend payable on December 14, 2026, to shareholders of record on November 20.

At September 30, cash and cash equivalents stood at $782.7 million, up from $756.2 million at December 31, 2025. Total investments declined to $4.46 billion from $4.54 billion over the same period. Stockholders’ equity increased 16% to $2.83 billion, while adjusted stockholders’ equity—which excludes specified unrealized investment and discount-rate effects—rose 4% to $2.50 billion. Primerica Life Insurance Company’s estimated statutory risk-based capital ratio was approximately 445%.

Investment Growth Was Largely Offset by Lower Term Life Profit

The quarter’s central issue was the earnings mix. Investment and Savings Products added approximately $59.2 million of adjusted operating revenue and $19.8 million of adjusted pre-tax operating income from a year earlier. However, Term Life adjusted operating income declined by approximately $20.0 million, almost fully offsetting the ISP profit increase.

As a result, total adjusted operating revenue increased by approximately $62.9 million, but adjusted operating income before taxes rose by only about $1.4 million. At the GAAP level, the smaller actuarial remeasurement gain also limited profit growth. The approximately 5% reduction in average diluted shares allowed EPS to increase 6% even though net income rose only 1%.

Recent Insider Transactions

The latest 10 reported transactions included five stock awards, one stock gift, and four sales. A separate six-month summary showed 10,416 shares purchased across 18 transactions and 6,879 shares sold across five transactions, resulting in net purchases of 3,537 shares; these figures do not by themselves indicate insiders’ outlook for the company.

The four reported sales totaled approximately $1.55 million. No conclusion about management’s view of Primerica’s prospects can be drawn from these transactions alone.

Risks Investors Should Watch

• Term Life distribution pressure: Declines in recruits, newly licensed representatives, policies issued, and issued face amount could weigh on future new-business production if they persist.
• Term Life profitability: Adjusted segment income fell 12% despite 3% growth in adjusted direct premiums and nearly flat net premiums, making the segment’s expense and actuarial trends important to monitor.
• Market-sensitive investment revenue: Favorable equity markets helped client asset values reach $139.6 billion. A reversal in market performance could reduce asset values and weaken related fee revenue.
• Limited consolidated operating leverage: Adjusted operating revenue rose 8%, but adjusted operating income before taxes increased by less than 1%, showing that higher revenue did not translate into comparable consolidated profit growth this quarter.

Summary

Primerica’s Q3 2026 growth came primarily from Investment and Savings Products, where sales, client assets, revenue, and profit all increased. Lower Term Life issuance and a 12% decline in that segment’s adjusted operating income prevented stronger revenue growth from producing similar profit growth, while a smaller actuarial gain further limited GAAP earnings. The main issues to monitor are whether life distribution stabilizes, investment inflows remain positive, and Term Life profitability improves following the annual assumption update.